Oppenheimer Starts Sutro Biopharma (STRO) at Outperform; sees ~200% upside
Tweet Send to a Friend
(Updated - October 5, 2023 4:27 PM EDT)
Oppenheimer analyst Jay Olson initiates coverage on Sutro Biopharma (NASDAQ: STRO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson initiates coverage on Sutro Biopharma (NASDAQ: STRO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
